Data-Driven Antibody Engineering Using Genedata Biologics™.

Methods Mol Biol

Genedata AG, Margarethenstrasse 38, 4053, Basel, Switzerland.

Published: February 2018

Genedata Biologics is a novel informatics platform specifically designed for biologics R&D. Here, we discuss the main principles employed in designing such a platform, focusing on antibody engineering. To illustrate, we present a case study of how the platform effectively supports an antibody optimization workflow and ensures the successful integration and analysis of all relevant sequence, expression, assay, and analytics data.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-6857-2_15DOI Listing

Publication Analysis

Top Keywords

antibody engineering
8
data-driven antibody
4
engineering genedata
4
genedata biologics™
4
biologics™ genedata
4
genedata biologics
4
biologics novel
4
novel informatics
4
informatics platform
4
platform designed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!